On May 9, 2024, the U.S. Department of Justice’s Antitrust Division (“DOJ”) announced a new task force to address “pressing antitrust problems in health care markets.” This new initiative, named the Task Force on Health Care Monopolies and Collusion (“HCMC”), will focus on DOJ’s view that there are “widespread competition concerns shared by patients, health care professionals, businesses and entrepreneurs, including issues regarding payer-provider consolidation, serial acquisitions, labor and quality of care, medical billing, health care IT ...
Blog Editors
Recent Updates
- Biometric Backlash: The Rising Wave of Litigation Under BIPA and Beyond
- Tasked with Troubling Content: AI Model Training and Workplace Implications
- Extraterritorial Application of the DTSA: Recent Decision Continues to Develop “Act in Furtherance” Element
- Shielding Reproductive Freedom: Uncovering New York’s Law Protecting Providers from Civil and Criminal Liability
- The Record-Setting First National Health Care Fraud Takedown of the Second Trump Administration: What Stayed the Same and What Is New?